When is recombinant luteinizing hormone supplementation beneficial during ovarian stimulation?

Affiliations

¹ Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Reproductive Science and Women's Health Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Free article

Editorial

Jacqueline Y Maher et al. Fertil Steril. 2018 Apr.

Free article

. 2018 Apr;109(4):611-612.

doi: 10.1016/j.fertnstert.2018.01.041.

¹ Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Reproductive Science and Women's Health Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.

No abstract available

Comment on

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.
Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Bühler K, Ferraretti AP, De Placido G, Mollo A, Fischer R, Humaidan P; International Collaborative Group for the Study of r-hLH (iCOS-LH). Alviggi C, et al. Fertil Steril. 2018 Apr;109(4):644-664. doi: 10.1016/j.fertnstert.2018.01.003. Fertil Steril. 2018. PMID: 29653717